Evidence map›Paper›PMID 33853770›Full record

ArticleScience advances2021

Establishing RNA-RNA interactions remodels lncRNA structure and promotes PRC2 activity.

Maggie M Balas, Erik W Hartwick, Chloe Barrington, Justin T Roberts, Stephen K Wu, Ryan Bettcher, April M Griffin, Jeffrey S Kieft, Aaron M Johnson

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Phosphorylation event changes the RNA binding mode of EZH2 disordered segment.Protein science : a publication of the Protein Society · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. HISTONE DEACETYLASE-1 is required for epigenome stability inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Maggie M BalasMolecular Biology Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-0701-1787
Erik W HartwickDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0001-9276-8567
Chloe BarringtonMolecular Biology Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-3884-102X
Justin T RobertsMolecular Biology Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0003-4433-1234
Stephen K WuMolecular Biology Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Ryan BettcherDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
April M GriffinDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0001-7091-7250
Jeffrey S KieftMolecular Biology Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-3718-1891
Aaron M JohnsonMolecular Biology Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. aaron.m.johnson@cuanschutz.edu.ORCID 0000-0003-4553-1078
University of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Structure, function, and dynamics of viral RNAs and RNA-containing complexesR35GM118070 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Jeffrey S Kieft · 2016 to 2026
$10.6M
Predoctoral Training Program in Molecular BiologyT32GM008730 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI PREKERIS, RYTIS, SCLAFANI, ROBERT A · 1999 to 2019
$3.3M
Mechanisms of heterochromatin targeting and epigenetic genome regulationR35GM119575 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI JOHNSON, AARON M. · 2016 to 2020
$1.9M
Role of hypoxia in altering hnRNP A2B1-mediated interaction with m6A to promote breast cancer progressionF31CA247343 · NCI · UNIVERSITY OF COLORADO DENVER · PI ROBERTS, JUSTIN T · 2020 to 2021
$61k
NCI NIH HHS F31 CA247343NCI NIH HHS P30 CA046934NIGMS NIH HHS R35 GM118070NIGMS NIH HHS R35 GM119575NIGMS NIH HHS T32 GM008730
6 · The paper itself

Abstract

Human Polycomb Repressive Complex 2 (PRC2) catalysis of histone H3 lysine 27 methylation at certain loci depends on long noncoding RNAs (lncRNAs). Yet, in apparent contradiction, RNA is a potent catalytic inhibitor of PRC2. Here, we show that intermolecular RNA-RNA interactions between the lncRNA HOTAIR and its targets can relieve RNA inhibition of PRC2. RNA bridging is promoted by heterogeneous nuclear ribonucleoprotein B1, which uses multiple protein domains to bind HOTAIR regions via multivalent protein-RNA interactions. Chemical probing demonstrates that establishing RNA-RNA interactions changes HOTAIR structure. Genome-wide HOTAIR/PRC2 activity occurs at genes whose transcripts can make favorable RNA-RNA interactions with HOTAIR. We demonstrate that RNA-RNA matches of HOTAIR with target gene RNAs can relieve the inhibitory effect of a single lncRNA for PRC2 activity after B1 dissociation. Our work highlights an intrinsic switch that allows PRC2 activity in specific RNA contexts, which could explain how many lncRNAs work with PRC2.

Identifiers

PMID33853770
PMCPMC8046370
OpenAlexW3153773392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.